Objectives Congenital heart defects (CHD) are the most common birth defects worldwide and are an important cause of morbidity and early death. A significant number of deaths occur among patients with infections. CHDs predispose to the development of infective endocarditis (IE) and represent a risk factor for increased mortality due to IE. The aim of this study was to investigate the occurrence and outcomes of IE in children and adolescents with CHDs.
Methods Data on all children with CHD and IE born in Norway between 1994 and 2016 were retrieved from the Oslo University Hospital’s Clinical Registry for Congenital Heart Defects. Survivors were followed through 2016, and supplementary information was retrieved from medical records.
Results In this nationwide register-based cohort study, which included all 1 357 543 live births in Norway between 1994 and 2016, the incidence of IE according to the European Society of Cardiology diagnostic criteria was 2.2 per 10 000 person-years among children and adolescents with CHDs. The incidence was stable throughout the period. Most patients with IE had severe CHDs (75%) and had undergone open chest cardiac surgery or catheter-based cardiac interventions the last year before IE. IE-related mortality among children with CHDs and IE was 8% during the follow-up period (mean 12.4 years (±5.5 years)).
Conclusions The incidence of IE among children and adolescents with CHDs was higher than the reported incidence in the general population. IE was associated with severe CHDs and recent complex cardiac interventions, and had significant mortality.
- congenital heart defect
- infective endocarditis
Statistics from Altmetric.com
Contributors JJ contributed to concept and design, acquisition, analysis and interpretation of data, drafting and revising the manuscript, approval of the manuscript, and is accountable for all aspects of the work. JK, LE, SB and GD contributed to acquisition and interpretation of data, revising the manuscript, approval of the manuscript and is accountable for all aspects of the work. HH contributed to concept and design, acquisition and interpretation of data, revising the manuscript, approval of the manuscript and is accountable for all aspects of the work.
Funding This work was supported by the Oslo University Hospital, Oslo, Norway, and the Sørlandet Hospital HF, Arendal, Norway. The funders had no role in the design and conduct of the study, in the collection, analysis and interpretation of the data, and in the preparation, review or approval of the manuscript.
Competing interests None declared.
Ethics approval The Regional Committee for Medical and Health Research Ethics of South East Norway approved this study.
Provenance and peer review Not commissioned; externally peer reviewed.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.